Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - penicillamine - oral tablet - 125mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - penicillamine - oral tablet - 250mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - penicillamine - oral tablet - 250mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

viatris uk healthcare ltd - penicillamine - oral tablet - 250mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - penicillamine - oral tablet - 250mg

Bandaríkin - enska - NLM (National Library of Medicine)

bluebay shandong co.,ltd - penicillamine (unii: gnn1dv99gx) (penicillamine - unii:gnn1dv99gx) -

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - penicillamine - oral tablet - 125mg

Bretland - enska - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - penicillamine - oral tablet - 250mg

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - penicillamine, quantity: 250 mg - tablet, film coated - excipient ingredients: povidone; stearic acid; microcrystalline cellulose; titanium dioxide; glycerol; hypromellose; sodium starch glycollate - severe, active rheumatoid arthritis. as a chelating agent in the treatment of wilson's disease and lead poisoning. d-penamine will enhance urinary excretion of gold and mercury and other heavy metals. in the treatment of cysturia in cases where high-fluid regimens are not adequate, or in conjunction with them.

Ástralía - enska - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - penicillamine, quantity: 125 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; povidone; glycerol; titanium dioxide; hypromellose; stearic acid; sodium starch glycollate - severe, active rheumatoid arthritis. as a chelating agent in the treatment of wilson's disease and lead poisoning. d-penamine will enhance urinary excretion of gold and mercury and other heavy metals. in the treatment of cysturia in cases where high-fluid regimens are not adequate, or in conjunction with them.